Immuno-oncology

Scroll to explore

Scroll back top

9 February 2023

PAR2 antagonist

A2aR/A2bR antagonist

EP4 receptor antagonist

Anti-CCR8 depleting antibody

26 February 2020

Undisclosed GPCR targets